PMK 044 Tab Constipation Relief
Natural health product licensed in Canada
- Licence holder
- PMK Federal Regulatory Consultants Ltd.
- NPN or DIN-HM
- 80040451
- Status
- Active licence
- Licence date
- 28 February 2013
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Dioxyde de silicium, Stéarate de magnésium, Cellulose microcristalline, Acide stéarique, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 2 Comprimé | 1 day |
Uses authorised in Canada
Used in Herbal Medicine as a stimulant laxative. Simulative laxative. Short-term relief of occasional constipation. Promotes bowel movement. Used in Herbal Medicine for the short-term relief of occasional constipation. Used in Herbal Medicine to promote bowel movement.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or breastfeeding. Do not use if you have abnormal constrictions of the gastrointestinal tract, potential or existing intestinal blockage, atonic bowel, appendicitis, inflammatory colon disease (e.g. Crohn's disease or ulcerative colitis), abdominal pain of unknown origin, undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes, hemorrhoids or diarrhoea.
- Effets indésirables connus
Hypersensitivity, such as an allergy, has been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80040451
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.